Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture for BCG-Related Adverse Events in Bladder Cancer
NCT04496219Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jan 2021
- Primary completion
- Aug 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Fred Hutchinson Cancer Center. Primary endpoints: Trial Recruitment: Number of Participants Eligible, Enrolled, and Not Enrolled, Trial Retention and 4 more. Started Jan 2021; status: completed.
Beyond the preview
Go deeper on NCT04496219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04496219.